Cliff Asness's INBX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 8,380 shares of Inhibrx Biosciences, Inc. (INBX) worth $563,387, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Cliff Asness has maintained this position in INBX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 5,998 shares. Largest reduction occurred in Q4 2024, reducing 13,012 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Inhibrx Biosciences (INBX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Inhibrx Biosciences (INBX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +879 | Add 11.72% | 8,380 | $67.23 |
| Q4 2025 | +1,503 | Add 25.06% | 7,501 | $79.00 |
| Q3 2025 | +5,998 | New Buy | 5,998 | $33.68 |
| Q4 2024 | -13,012 | Sold Out | 0 | $0.00 |
| Q3 2024 | +13,012 | New Buy | 13,012 | $15.66 |
Cliff Asness's Inhibrx Biosciences Investment FAQs
Cliff Asness first purchased Inhibrx Biosciences, Inc. (INBX) in Q3 2024, acquiring 13,012 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Inhibrx Biosciences, Inc. (INBX) for 5 quarters since Q3 2024.
Cliff Asness's largest addition to Inhibrx Biosciences, Inc. (INBX) was in Q3 2024, adding 13,012 shares worth $203,768.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 8,380 shares of Inhibrx Biosciences, Inc. (INBX), valued at approximately $563,387.
As of the Q1 2026 filing, Inhibrx Biosciences, Inc. (INBX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Inhibrx Biosciences, Inc. (INBX) was 13,012 shares, as reported at the end of Q3 2024.